PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages

J Exp Clin Cancer Res. 2022 Oct 14;41(1):303. doi: 10.1186/s13046-022-02477-0.

Abstract

Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the ninth member of the proprotein convertase family that regulates lipoprotein homeostasis and altered PCSK9 expression was reportedly associated with tumor development and progression. This study assessed PCSK9 expression and functions in human colon cancer and then explored the underlying molecular events.

Methods: Colon cancer tissues were utilized for analysis of PCSK9 expression for association with clinicopathological factors from patients by immunohistochemistry assay. Manipulation of PCSK9 expression was assessed in vitro and in vivo for colon cancer cell proliferation, migration, and invasion using cell viability CCK-8, Transwell tumor cell migration and invasion, and wound-healing assays. Next, proteomic analysis, Western blot, qRT-PCR and Flow cytometry were conducted to assess downstream targets and tumor cell-derived PCSK9 action on macrophage polarization.

Results: PCSK9 expression was upregulated in colon cancer tissues versus the normal tissues, and associated with advanced tumor pathological grade. Knockdown of PCSK9 expression reduced colon cancer cell proliferation, migration, and invasion and suppressed tumor metastasis in vivo. PCSK9 directly or indirectly upregulated Snail 1 and in turn to downregulate E-cadherin expression, but upregulate N-cadherin and MMP9 levels and thereafter, to induce colon cancer cell epithelial-mesenchymal transition (EMT) process and activated PI3K/AKT signaling. However, PCSK9 overexpression showed the inverse effects on colon cancer cells. Knockdown of PCSK9 expression inhibited M2 macrophage polarization, but also promoted M1 macrophage polarization by reduction of lactate, protein lactylation and macrophage migration inhibitory factor (MIF) levels.

Conclusion: PCSK9 played an important role in the progression and metastasis of colon cancer by regulation of tumor cell EMT and PI3K/AKT signaling and in the phenotypic polarization of macrophages by mediating MIF and lactate levels. Targeting PCSK9 expression or activity could be used to effectively control colon cancer.

Keywords: AKT; Colon cancer; EMT; Macrophage polarization; PCSK9; PI3K.

MeSH terms

  • Cadherins / metabolism
  • Cell Movement
  • Colonic Neoplasms* / pathology
  • Epithelial-Mesenchymal Transition
  • Humans
  • Lactates / pharmacology
  • Macrophage Migration-Inhibitory Factors*
  • Matrix Metalloproteinase 9
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proprotein Convertase 9 / genetics
  • Proteomics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Sincalide / pharmacology
  • Subtilisins / pharmacology

Substances

  • Cadherins
  • Lactates
  • Macrophage Migration-Inhibitory Factors
  • Matrix Metalloproteinase 9
  • PCSK9 protein, human
  • Phosphatidylinositol 3-Kinases
  • Proprotein Convertase 9
  • Proto-Oncogene Proteins c-akt
  • Sincalide
  • Subtilisins